|4Aug 25, 4:57 PM ET

Bonner Michael 4

4 · CUMBERLAND PHARMACEUTICALS INC · Filed Aug 25, 2017

Insider Transaction Report

Form 4
Period: 2017-08-23
Bonner Michael
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2017-08-23$6.72/sh+500$3,36015,447 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION